JILL ZDAN: Open Payments
NPI 1477064665 · PHOENIX, AZ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,333 in 54 payments from 14 companies in 2025. Trend: 2023 $607 · 2024 $1,086 · 2025 $1,333
Food & beverage: $1,134Education: $199
| Company | Payments | Amount |
|---|---|---|
| GENZYME CORPORATION | 12 | $310 |
| Regeneron Healthcare Solutions, Inc. | 8 | $267 |
| SUN PHARMACEUTICAL INDUSTRIES INC. | 6 | $167 |
| PFIZER INC. | 5 | $117 |
| UCB, Inc. | 3 | $82 |
| ABBVIE INC. | 4 | $80 |
| Janssen Biotech, Inc. | 4 | $70 |
| Botanix SB Inc | 2 | $61 |
| Amgen Inc. | 3 | $57 |
| Lilly USA, LLC | 3 | $54 |
Products named: DUPIXENT, CIBINQO, Bimzelx, TREMFYA, SOFDRA, SKYRIZI, OTEZLA, TALTZ.
Industry payments across AZ — which companies pay providers there.
